Home
Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.
Upcoming as of 2026-11-19 , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.
8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.
Add to your calendar (calendar.ics)
The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.
Upcoming
February 2028 67
2028-02
Study completion A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06305559
2028-02
Primary completion Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06310031
2028-02
Primary completion J-Valve Transfemoral Pivotal Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06455787
2028-02
Study completion The PERSEVERE Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06588634
2028-02
2028-02
2028-02
2028-02
Study completion Developing a Digital Aid to Improve ICD Decisions Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07084142
2028-02
Study completion A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07282600
2028-02
2028-02
2028-02
Primary completion HEARTS in Sync + CardioWatch 287-2 Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07322510
2028-02
Study completion Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07444320
2028-02
Primary completion Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07444320
2028-02
Primary completion Evaluating Bu Yang Huanwu Decoction For Early Diabetic Vascular Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07658807
2028-02
2028-02
2028-02
Study completion A Phase II Study of VB19055 in Uncontrolled or Resistant Hypertension Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07833098
2028-02
2028-02
Study completion Evaluating a Digital Aid to Improve ICD Decisions Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07913204
2028-02-03
2028-02-03
2028-02-04
2028-02-05
2028-02-05
2028-02-15
Study completion CorVad Myocardial Infarction Complicated with Cardiogenic Shock Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06886113
2028-02-17
Primary completion Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07149714
2028-02-20
2028-02-20
Study completion Stenting Versus Drug Eluting Balloons Only in Treatment of Coronary Bifurcation Lesion (ROBUST Study) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07552194
2028-02-23
2028-02-24
2028-02-24
2028-02-24
2028-02-27
Study completion Restoring Sinus Rhythm Using Dual-Shock Technique in Patients With Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07560644
2028-02-28
2028-02-28
Study completion Brain-Oscillation-Synchronized Stimulation to Enhance Motor Recovery in Early Subacute Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05600374
2028-02-28
Primary completion Novel Approach to Conduction System Pacing With Use of Ultrasound Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06815783
2028-02-28
2028-02-28
Study completion QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07444086
2028-02-28
2028-02-28
Study completion Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07523620
2028-02-29
2028-02-29
2028-02-29
2028-02-29
Study completion Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06987305
2028-02-29
2028-02-29
Primary completion Tenecteplase for Late-Window Stroke Guided by DWI-FLAIR Mismatch Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07540416
2028-02-29
2028-02-29
2028-02-29
2028-02-29
Study completion Using Non-Invasive Mapping To Eliminate Structural Heart Disease Ventricular Tachycardia Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07759427
2028-02-29
March 2028 88
2028-03-01
2028-03-01
2028-03-01
2028-03-01
Primary completion Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06071429
2028-03-01
2028-03-01
2028-03-01
2028-03-01
2028-03-01
Primary completion Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07168278
2028-03-01
Study completion Microwave Ablation for Treatment of Vascular Malformations: Efficacy and Safety Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07404670
2028-03-01
Primary completion Microwave Ablation for Treatment of Vascular Malformations: Efficacy and Safety Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07404670
2028-03-01
Primary completion Safety and Efficacy of J147 in Acute Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07430917
2028-03-01
Study completion Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07441382
2028-03-01
2028-03
Primary completion CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent Graft Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT02089607
2028-03
2028-03
2028-03
Study completion Pulmonary Embolism International THrOmbolysis Study-3 Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04430569
2028-03
2028-03
Primary completion MYTHS - MYocarditis THerapy With Steroids Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05150704
2028-03
Primary completion Bimanual Motor Skill Learning in Acute Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05760846
2028-03
2028-03
2028-03
Study completion Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06078436
2028-03
2028-03
Study completion SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06955260
2028-03
Primary completion CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06994975
2028-03
2028-03
Study completion Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07223892
2028-03
2028-03
Study completion Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07246629
2028-03
Primary completion Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07246629
2028-03
2028-03
2028-03
Primary completion Trial Phase: Syndemic Adapted Medly Uganda Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07525271
2028-03
2028-03
2028-03
Study completion Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07747402
2028-03
Primary completion Single-Use Spherical Pulsed Ablation Catheter for Paroxysmal Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07811934
2028-03
2028-03
Primary completion Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07824323
2028-03
2028-03
2028-03
2028-03-08
Primary completion Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05611242
2028-03-14
2028-03-15
2028-03-15
Overdue
The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.
2023-01
Study completion Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions Registry record
Expected 2023-01; that period ended on 2023-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04744571
2023-01
Study completion Effect of Levosimendan on Left Ventricular Systolic Function and Heart Failure After PCI in Patients With Acute Anterior Myocardial Infarction Registry record
Expected 2023-01; that period ended on 2023-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04970238
2023-01
Primary completion Effect of Levosimendan on Left Ventricular Systolic Function and Heart Failure After PCI in Patients With Acute Anterior Myocardial Infarction Registry record
Expected 2023-01; that period ended on 2023-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04970238
2023-01
Study completion Assessment of Intracerebral Hematoma Registry record
Expected 2023-01; that period ended on 2023-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05158660
2023-01
Study start Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds Registry record
Expected 2023-01; that period ended on 2023-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05589454
2023-02-01
Primary completion Effect of EA Combined With NGF on Limb Function in Convalescent Patients With Ischemic Stroke Registry record
Expected 2023-02-01; that period ended on 2023-02-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05652751
2023-02-01
Study start Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia Registry record
Expected 2023-02-01; that period ended on 2023-02-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05691257
2023-02-01
Study start Safety and Efficacy of Evolocumab in Ischemic Stroke Registry record
Expected 2023-02-01; that period ended on 2023-02-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05697185
2023-02-05
Study start rTMS in Chronic Poststroke Dysphagia Registry record
Expected 2023-02-05; that period ended on 2023-02-05.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05590819
2023-02-06
Study start Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD Registry record
Expected 2023-02-06; that period ended on 2023-02-06.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05580510
2023-02-15
Study start Research on Diagnosis and Prognosis of Myocardial Ischemia Level Using Magnetocardiography Registry record
Expected 2023-02-15; that period ended on 2023-02-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05718206
2023-02
Primary completion Early Vascular Adjustments During Hypertensive Pregnancy Registry record
Expected 2023-02; that period ended on 2023-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02531490
2023-02-28
Study completion Effects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF Trial Registry record
Expected 2023-02-28; that period ended on 2023-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04696120
2023-02-28
Study completion Prophylactic Amiodarone for Shockable Cardiac Arrest Registry record
Expected 2023-02-28; that period ended on 2023-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04845607
2023-02-28
Primary completion Prophylactic Amiodarone for Shockable Cardiac Arrest Registry record
Expected 2023-02-28; that period ended on 2023-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04845607
2023-02
Study completion Sacubitril/Valsartan Versus Valsartan for Hypertensive Patients With Acute Myocardial Infarction Registry record
Expected 2023-02; that period ended on 2023-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05060588
2023-02-28
Study completion BUN/Cr-based Hydration Therapy to Improve Outcome of Patients With Acute Ischemic Stroke Registry record
Expected 2023-02-28; that period ended on 2023-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05121389
2023-02
Study start Safety Study of Intracranial Support Catheter and Guide Catheter for Stent-Assisted Embolization in the Treatment of Intracranial Aneurysms Registry record
Expected 2023-02; that period ended on 2023-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05524285
2023-02
Study start The Effect of Intravenous Iron Therapy and Erythropoiesis-stimulation Agent Combination on Renal Transplant Outcomes Registry record
Expected 2023-02; that period ended on 2023-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05719376
2023-02-28
Study start A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus Registry record
Expected 2023-02-28; that period ended on 2023-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05759897
2023-03-01
Primary completion Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients Registry record
Expected 2023-03-01; that period ended on 2023-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04135287
2023-03-01
Primary completion Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris Registry record
Expected 2023-03-01; that period ended on 2023-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04661709
2023-03-01
Primary completion Edaravone Dexborneol for Treatment of Hypertensive Intracerebral Hemorrhage Registry record
Expected 2023-03-01; that period ended on 2023-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04714177
2023-03-01
Study start Study of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke Registry record
Expected 2023-03-01; that period ended on 2023-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05745311
2023-03-03
Primary completion Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock Registry record
Expected 2023-03-03; that period ended on 2023-03-03.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03813134
2023-03-10
Primary completion TReAtmeNt of Small Coronary Vessels: MagicTouch Sirolimus Coated Balloon Registry record
Expected 2023-03-10; that period ended on 2023-03-10.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03913832
2023-03-15
Primary completion Early Hydrogen-Oxygen Gas Mixture Inhalation in Patients With Aneurysmal Subarachnoid Hemorrhage (HOMA) Registry record
Expected 2023-03-15; that period ended on 2023-03-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05282836
2023-03-15
Study start Safety and Efficacy of DIDALA Monotherapy in Patients With Type 2 Diabetes Compared With Metformin. Registry record
Expected 2023-03-15; that period ended on 2023-03-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05760456
2023-03-23
Study completion Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes Patients Registry record
Expected 2023-03-23; that period ended on 2023-03-23.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04932928
2023-03-30
Study completion A Non-Traumatic Binder for Temporary Abdominal Wall Closure Registry record
Expected 2023-03-30; that period ended on 2023-03-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT03815370
2023-03-30
Study completion Intravascular Ultrasound Versus Angiography Guided Drug-coated Balloon Treatment for STEMI Patients:a Prospective, Multicenter, Randomized Controlled Trial Registry record
Expected 2023-03-30; that period ended on 2023-03-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04475978
2023-03-30
Primary completion A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic Stroke Registry record
Expected 2023-03-30; that period ended on 2023-03-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05188417
2023-03
Study completion Sodium Thiosulfate to Preserve Cardiac Function in STEMI Registry record
Expected 2023-03; that period ended on 2023-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02899364
2023-03-31
Study completion Remote Ischemic Conditioning Paired With Endovascular Treatment for Acute Ischemic Stroke Registry record
Expected 2023-03-31; that period ended on 2023-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03045055
2023-03
Study completion Effect of Preoperative Iron Isomaltoside 1000 Administration on Hemoglobin Concentration in Patients Undergoing Transcatheter Aortic Valve Implantation Registry record
Expected 2023-03; that period ended on 2023-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04346004
2023-03
Primary completion Effect of Preoperative Iron Isomaltoside 1000 Administration on Hemoglobin Concentration in Patients Undergoing Transcatheter Aortic Valve Implantation Registry record
Expected 2023-03; that period ended on 2023-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04346004
2023-03-31
Study completion Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke Registry record
Expected 2023-03-31; that period ended on 2023-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04491695
2023-03
Study start Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia Registry record
Expected 2023-03; that period ended on 2023-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04603508
2023-03-31
Primary completion Remote Blood Pressure Management Clinical Application Research Registry record
Expected 2023-03-31; that period ended on 2023-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04690478
2023-03
Primary completion An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients Registry record
Expected 2023-03; that period ended on 2023-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05089435
2023-03
Primary completion Continuous Ambulatory Cardiac Monitoring for Recurrent Atrial Fibrillation After Sepsis Registry record
Expected 2023-03; that period ended on 2023-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05217485
2023-03
Study start Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease Registry record
Expected 2023-03; that period ended on 2023-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05373004
2023-03
Study start CAtheter-Based Ablation of Atrial Fibrillation Compared to Conventional Treatment in Patients With Heart Failure With Preserved Ejection Fraction Registry record
Expected 2023-03; that period ended on 2023-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05508256
2023-03
Primary completion TWIN2WIN (Double Stent (DS-EVT) Versus Primary Thrombectomy With One Stent (SS-EVT)) Registry record
Expected 2023-03; that period ended on 2023-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05632458
2023-04-01
Study completion Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT Registry record
Expected 2023-04-01; that period ended on 2023-04-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05124353
2023-04-01
Primary completion Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT Registry record
Expected 2023-04-01; that period ended on 2023-04-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05124353
2023-04-01
Primary completion Low-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary Syndrome Registry record
Expected 2023-04-01; that period ended on 2023-04-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05298475
2023-04-01
Primary completion Evidence for Health Improvement in People With Diabetes Using One Touch & Partner Solutions Registry record
Expected 2023-04-01; that period ended on 2023-04-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05354297
2023-04-01
Study start NanO2 for Large Vessel Occlusion Stroke Registry record
Expected 2023-04-01; that period ended on 2023-04-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05389748
2023-04-01
Study start Follow up of Clinical Outcome of Deferred vs Immediate Stenting in High Thrombus Stemi Patients Registry record
Expected 2023-04-01; that period ended on 2023-04-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05793671
2023-04-05
Study start Rivaroxaban Versus Standard of Care for Patients With Excessive Atrial Ectopy or Short Atrial Runs and High Embolism Risk Registry record
Expected 2023-04-05; that period ended on 2023-04-05.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05487950
2023-04-20
Study start The Effects of Allicor on Patients After Revascularization Treatment During a Year Registry record
Expected 2023-04-20; that period ended on 2023-04-20.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05813171
2023-04-22
Study completion The Puncturable Atrial Septal Defect Occluder Trial (the PASSER Trial) Registry record
Expected 2023-04-22; that period ended on 2023-04-22.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05371366
2023-04-22
Primary completion The Puncturable Atrial Septal Defect Occluder Trial (the PASSER Trial) Registry record
Expected 2023-04-22; that period ended on 2023-04-22.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05371366
2023-04
Study completion Early Vascular Adjustments During Hypertensive Pregnancy Registry record
Expected 2023-04; that period ended on 2023-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02531490
2023-04
Primary completion Biolimus A9™ (BA9™) Drug Coated Balloon (DCB) Study Registry record
Expected 2023-04; that period ended on 2023-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04079192
2023-04
Primary completion Prevention of Post-Operative Cardiac Arrhythmias Registry record
Expected 2023-04; that period ended on 2023-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04234906
2023-04
Study completion Safety & Clinical Performance Study of Catheter Ablation With the Centauri System for Patients With Atrial Fibrillation Registry record
Expected 2023-04; that period ended on 2023-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04523545
2023-04
Primary completion Safety & Clinical Performance Study of Catheter Ablation With the Centauri System for Patients With Atrial Fibrillation Registry record
Expected 2023-04; that period ended on 2023-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04523545
2023-04-30
Primary completion Endovascular Treatment and RIPC in Acute Ischemic Stroke Registry record
Expected 2023-04-30; that period ended on 2023-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04581759
2023-04
Study completion A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease Registry record
Expected 2023-04; that period ended on 2023-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04953117
2023-05-01
Study completion Mobile Health to Enhance Exercise in Type 2 Diabetes Registry record
Expected 2023-05-01; that period ended on 2023-05-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04653532
2023-05-01
Primary completion Cryoablation With Vestibular Expansion for the Treatment of Paroxysmal/Short-course Persistent Atrial Fibrillation Registry record
Expected 2023-05-01; that period ended on 2023-05-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05311098
2023-05-01
Primary completion Clinical Trial in China Registry record
Expected 2023-05-01; that period ended on 2023-05-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05580952
2023-05-01
Study completion Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial Infarct Registry record
Expected 2023-05-01; that period ended on 2023-05-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05709509
2023-05-01
Primary completion Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial Infarct Registry record
Expected 2023-05-01; that period ended on 2023-05-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05709509
2023-05-01
Study start A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergency Registry record
Expected 2023-05-01; that period ended on 2023-05-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05783557
2023-05-01
Study start The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole) Registry record
Expected 2023-05-01; that period ended on 2023-05-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05820048
2023-05-01
Study start tDCS and rTMS in Patients With Early Disorders of Consciousness Registry record
Expected 2023-05-01; that period ended on 2023-05-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05820178
2023-05-03
Primary completion Screening of OSA in Hospitalized Stroke Patients Using BSP Registry record
Expected 2023-05-03; that period ended on 2023-05-03.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05466864
2023-05-05
Study completion Impact of NIRS-guided Cardiopulmonary Resuscitation After Cardiac Arrest on Resuscitation Rate Registry record
Expected 2023-05-05; that period ended on 2023-05-05.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03911908
2023-05-10
Study completion Effects of Dapagliflozin and Metformin on Vascular Function in Newly-Diagnosed Treatment-Naive Type 2 Diabetes Registry record
Expected 2023-05-10; that period ended on 2023-05-10.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05440591
2023-05-10
Primary completion Effects of Dapagliflozin and Metformin on Vascular Function in Newly-Diagnosed Treatment-Naive Type 2 Diabetes Registry record
Expected 2023-05-10; that period ended on 2023-05-10.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05440591
2023-05-15
Primary completion Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver Registry record
Expected 2023-05-15; that period ended on 2023-05-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04976283
2023-05-17
Primary completion Intracoronary of Nicorandil and Verapamil to Reduce the Occurrence of Periprocedural Myocardial Injury Registry record
Expected 2023-05-17; that period ended on 2023-05-17.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05399576
2023-05-30
Study completion Preventive Care System Application Effectiveness Study on the Treatment of Diabetic Patients in Bandung Registry record
Expected 2023-05-30; that period ended on 2023-05-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05657769
2023-05-30
Primary completion Preventive Care System Application Effectiveness Study on the Treatment of Diabetic Patients in Bandung Registry record
Expected 2023-05-30; that period ended on 2023-05-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05657769
2023-05-30
Primary completion The Safety and Efficacy of the Suture-Mediated Closure System Registry record
Expected 2023-05-30; that period ended on 2023-05-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05841836
2023-05
Study completion The Adult Hemorrhagic Moyamoya Surgery Study Registry record
Expected 2023-05; that period ended on 2023-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02319980
2023-05
Primary completion The Adult Hemorrhagic Moyamoya Surgery Study Registry record
Expected 2023-05; that period ended on 2023-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02319980
2023-05
Study completion Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study) Registry record
Expected 2023-05; that period ended on 2023-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02494895
2023-05
Primary completion Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study) Registry record
Expected 2023-05; that period ended on 2023-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02494895
2023-05
Primary completion Investigating the Use of Genetics to Guide Pharmacologic Therapy for Hypertension Registry record
Expected 2023-05; that period ended on 2023-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02988245
2023-05-31
Study completion Strengthening Referral Networks for Management of Hypertension Across the Health System (STRENGTHS) Registry record
Expected 2023-05-31; that period ended on 2023-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03543787
2023-05-31
Primary completion Strengthening Referral Networks for Management of Hypertension Across the Health System (STRENGTHS) Registry record
Expected 2023-05-31; that period ended on 2023-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03543787
2023-05-31
Study completion Atrial Sensing Capability for Better Detection of Atrial Fibrillation Registry record
Expected 2023-05-31; that period ended on 2023-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03932604
2023-05-31
Primary completion Implementing Precision Medicine Approaches to Guide Anti-platelet Selection Registry record
Expected 2023-05-31; that period ended on 2023-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04090281
2023-05-31
Study completion Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke Registry record
Expected 2023-05-31; that period ended on 2023-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04415164
2023-05
Study start Semaglutide to Reduce Atrial Fibrillation Burden Registry record
Expected 2023-05; that period ended on 2023-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05209165
2023-05-31
Study completion Influenza Vaccination During Coronavirus Disease 2019 Outbreak After Acute Coronary Syndrome and Chronic Heart Failure Registry record
Expected 2023-05-31; that period ended on 2023-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05232292
2023-05
Primary completion Tenecteplase Compared to Alteplase for Patients With Large Vesel Oclusion Suspicion Before Thrombectomy Registry record
Expected 2023-05; that period ended on 2023-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05626972
2023-05
Study start Clinical Outcomes of CT-FFR Versus QFR-guided Strategy for Decision-Making in Patients With Stable Chest Pain Registry record
Expected 2023-05; that period ended on 2023-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05857904
2023-06-01
Primary completion Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries. Registry record
Expected 2023-06-01; that period ended on 2023-06-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03423511
2023-06-01
2023-06-01
Primary completion Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve Implantation Registry record
Expected 2023-06-01; that period ended on 2023-06-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04171726
2023-06-01
Study completion Effects of SGLT2 Inhibitor on Type 2 Diabetic Patients Undergoing Cardiac Surgery Registry record
Expected 2023-06-01; that period ended on 2023-06-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04340908
2023-06-01
Study completion Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris Registry record
Expected 2023-06-01; that period ended on 2023-06-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04661709
2023-06-01
Study completion Effect of EA Combined With NGF on Limb Function in Convalescent Patients With Ischemic Stroke Registry record
Expected 2023-06-01; that period ended on 2023-06-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05652751
2023-06-01
Study start Effect of Azilsartan on Atrial Fibrillation in Patients With Hypertension Registry record
Expected 2023-06-01; that period ended on 2023-06-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05841654
2023-06-01
Study start A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome Registry record
Expected 2023-06-01; that period ended on 2023-06-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05843162